BioSpace News Archive

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced a shift in focus to advance its core technology.

Valo Health, Inc (“Valo”), the technology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence, announced that David Berry, founder & CEO of Valo will present at the UBS Biotechnology Virtual Private Company Symposium on September 22, 2022 from 11:30 AM EST to 11:55 AM EST.

Protagonist Therapeutics, Inc. reported that on September 15, 2022, it issued an inducement award to Pedro Oyuela, M.D., the Company’s recently hired Vice President of Pharmacovigilance, in accordance with the terms of Dr. Oyuela’s employment offer letter.

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports the final results from the IPAX-1 Ph I/II study of TLX101 therapy (4-L-[ 131I] iodo-phenylalanine, or 131I-IPA) in combination with external beam radiation therapy (EBRT) in recurrent glioblastoma multiforme (GBM).

Alpine Immune Sciences, Inc. announced the pricing of its underwritten public offering of 13,606,000 shares of its common stock pursuant to its existing shelf registration statement.

Glyscend Therapeutics today reported additional biomarker results from their Phase 1 study of GLY-200, a proprietary orally administered, gut-restricted therapeutic for the treatment of type 2 diabetes (T2D).

Purigen Biosystems, Inc. today announced a new distribution agreement with Bucher Biotec AG.

Enclara Pharmacia has announced the appointment of Tim Sanderson as Vice President, Business Development.

MyMD Pharmaceuticals ® Provides Dosing Update on Phase 2 Multi-Center Clinical Trial of MYMD-1 ® as a Therapy for Delaying Aging and Extending Healthy Lifespan.

Babson Diagnostics, a science-first health care technology company, today announced that it continues to grow its management team with the addition of four key leaders.